We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
14 hedge funds and large institutions have $3.76M invested in COSCIENS Biopharma Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
18% less funds holding
Funds holding: 17 → 14 (-3)
31% less capital invested
Capital invested by funds: $5.46M → $3.76M (-$1.71M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$95.6K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$72.2K |
| 3 |
Jane Street
New York
|
+$64.9K |
| 4 |
Millennium Management
New York
|
+$62.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$47.1K |
